Sofosbuvir based regimens in the treatment of chronic hepatitis C genotype 1 infection in African-American patients: a community-based retrospective cohort study.

Gayam, Vijay

Sofosbuvir based regimens in the treatment of chronic hepatitis C genotype 1 infection in African-American patients: a community-based retrospective cohort study. [electronic resource] - European journal of gastroenterology & hepatology 10 2018 - 1200-1207 p. digital

Publication Type: Journal Article

1473-5687

10.1097/MEG.0000000000001233 doi


Adult
Black or African American
Aged
Aged, 80 and over
Antiviral Agents--adverse effects
Benzimidazoles--adverse effects
Carbamates--adverse effects
Community Health Centers
Drug Therapy, Combination--adverse effects
Female
Fluorenes--adverse effects
Genotype
Hepacivirus--genetics
Hepatitis C, Chronic--drug therapy
Heterocyclic Compounds, 4 or More Rings--adverse effects
Humans
Male
Middle Aged
Retrospective Studies
Ribavirin--therapeutic use
Simeprevir--adverse effects
Sofosbuvir--adverse effects
Sustained Virologic Response